Gonadal and adrenal sex steroids in ankylosing spondylitis

Rheumatic Disease Clinics of North America

Volumn 26, Issue 4, 2000, Pages 969-987

  Gooren, Louis J G ^a   Giltay, Erik J ^c   Van Schaardenburg, Dirkjan ^b   Dijkmans, Ben A C ^b  

^a Division of Andrology   (Netherlands)

^b Department of Rheumatology ^*

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; FOLLITROPIN; HLA B27 ANTIGEN; HYDROXYPROGESTERONE; LUTEINIZING HORMONE; PRASTERONE; PRASTERONE SULFATE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEX HORMONE; STEROID 11BETA MONOOXYGENASE; STEROID 21 MONOOXYGENASE; TESTOSTERONE;

ADRENAL GLAND; ANKYLOSING SPONDYLITIS; BODY COMPOSITION; GONAD; HUMAN; INFLAMMATORY DISEASE; ONSET AGE; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; REVIEW; SEX RATIO;

EID: 0033777684     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70179-4     Document Type: Article

References (101)

1. Sex hormones and the immune system-animal data
2. Dihydrotestosterone exerts a depressive influence on the production of interleukin-4, IL-5 and TNF, but not IL-2 by activated murine cells
3. Sex hormones in spondylarthropathies: A study in 57 patients
4. Smoking and estrogen-related disease
5. Dehydroepiandrosterone (DHEA): A fountain of youth?
6. Short term ethanol ingestion can affect the testicular response to single-dose human chorionic gonadotropin in normal subjects
7. The effect of nutritional factors on sex hormone levels in male twins
8. Ankylosing spondylitis in men and women: A clinical and radiographic comparison
9. Loss of circadian rhythmicity in blood testosterone levels with ageing in normal men
10. Bone mineral density and biochemical markers of bone metabolism in ankylosing spondylitis
11. Androgen effects on body composition and muscle function: Implications for the use of androgens as anabolic agents in sarcopenic states
12. A genome-wide screen for susceptibility loci in ankylosing spondylitis
13. Susceptibility to ankylosing spondylitis in twins
14. Influence of sex in immunoglobulin levels
15. Ankylosing spondylitis-an analytical review of 1500 patients: The changing pattern of disease
16. Sex hormone concentrations in male patients with anylosing spondylitis: Preliminary report
17. Prolactin and neuroimmunomodulation: In vitro and in vivo observations
18. Sex steroid receptors in peripheral T cells: Absence of androgen receptors and restriction of estrogen receptors to OKT8-positive cells
19. Sex hormones, HLA and rheumatoid arthritis
20. Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function
21. Integrated concentration and circadian variation of plasma testosterone in normal men
22. Molecular mimicry: The geographical distribution of immune responses to Klebsiella in ankylosing spondylitis and its relevance to therapy
23. Studies of the regulatory effects of the sex hormones on antibody formation and stem cell differentiation
24. The pathogenetic role of HLA-B27
25. The relation of smoking, age, relative weight, and dietary intake to serum steroids, sex hormones, and sex-hormone-binding globulin in middle-aged men
26. Serum osteocalcin and vitamin D metabolites in patients with ankylosing spondylitis
27. The epidemiology of gender-discrepant illness
28. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects
29. Androgens and ankylosing spondylitis: A role in the pathogenesis?
30. Decreased serum biochemical markers of muscle origin in patients with ankylosing spondylitis
31. Serum testosterone levels are not elevated in patients with ankylosing spondylitis
32. Ovaries
33. Juvenile onset ankylosing spondylitis-more girls than we thought?
34. One and the same androgen for all? Towards designer androgens
35. Androgenic status and sexual function in males with rheumatoid arthritis and ankylosing spondylitis
36. Ankylosing spondylitis in women
37. The epidemiology of ankylosing spondylitis
38. The outcome of ankylosing spondylitis: A study of 100 patients
39. Radiological changes in men and women with ankylosing spondylitis
40. Age, disease, and changing sex hormone levels in middle-aged men: Results of the Massachusetts Male Aging Study
41. Sex steroid regulation of autoimmunity
42. Human X chromosome carries quantitative genes for immunoglobulin
43. Bechterew's syndrome in women: Is it different from that in men?
44. Reduction of the risk of rheumatoid arthritis among women who take oral contraceptives
45. Clinical diagnosis of ankylosing spondylitis in women and relation to presence of HLA-B27
46. Epidemiology and estimated population burden of selected autoimmune diseases in the United States
47. Might patients with HLA-B27 related diseases benefit from anti-androgenic treatment?
48. Sex ratios and hormones in HLA related rheumatic disease
49. Ankylosing spondylitis: Clinical course in women and men
50. Ovarian function studies in active ankylosing spondylitis in women. Clinical response to estrogen treatment
51. Spondylitic disease without radiologic evidence of sacroiliitis in relatives of HLA-B27 positive ankylosing spondylitis patients
52. Sex ratio in the spondylarthropathies and its relationship to phenotypic expression, mode of inheritance and age at onset
53. Disease expression of ankylosing spondylitis in males and females
54. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS
55. Androgen receptors in human thymocytes
56. Effector cell activity in antibody-mediated cell-dependent immune lympholysis
57. The risk of sacroiliitis in B27 positive persons: A reappraisal
58. The distribution of serum immunoglobulins, anti-gamma-G globulins ('rheumatoid factors') and antinuclear antibodies in White and Negro subjects in Evans County, Georgia
59. Why women?
60. Sex ratio in spondylarthropathies
61. Natural cell-mediated cytotoxicity in normal human peripheral blood lymphocytes and its in vitro boosting with BCG
62. Cytokines and the endocrine system: The immunoendocrine network
63. HLA-B27 derived peptides as autoantigens for T lymphocytes in ankylosing spondylitis
64. Ankylosing spondylitis in women and men: A case-control study
65. The endocrinology of pregnancy
66. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy
67. Do sex hormones play a role in ankylosing spondylitis?
68. Hormonal and pregnancy relationships to rheumatoid arthritis: Convergent effects with immunologic and microvascular systems
69. The control of adrenal androgen secretion
70. The spectrum of mutations in the androgen receptor gene that causes androgen resistance: Genetic basis of endocrine disease 4
71. Ankylosing spondylitis, HLA B27, and beyond
72. Are certain HLA haplotypes responsible for low testosterone levels in males?
73. Gonadal steroids and immunity
74. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood
75. Sex hormones and pregnancy in rheumatoid arthritis and systemic lupus erythematosus
76. Ankylosing spondylitis-the female aspect
77. A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis
78. Ankylosing spondylitis and motherhood
79. Sex-based differences in gene transmission and gene expression
80. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones
81. Rheumatoid spondylitis: A study of 1035 cases
82. Studies of human natural killer cells: In vivo parameters affecting normal cytotoxic function
83. Clinical and radiographic abnormalities in ankylosing spondylitis: A comparison of men and women
84. Genotype-phenotype analysis in late onset 21-hydroxylase deficiency in comparison to the classical forms
85. HLA-related control of spontaneous and antibody-dependent cell-mediated cytotoxic activity in humans
86. Etiopathogenesis and biochemical and immunological evaluation of spondylarthropathies
87. Circannual cycle in plasma testosterone levels in man
88. Influence of ovarian hormones on urogenital infection
89. Free and serum testosterone levels in 276 males: A comparative study of rheumatoid arthritis, ankylosing spondylitis and healthy controls
90. Reproductive axis suppression in acute illness is related to disease severity
91. Dehydroepiandrosterone enhances IL-2 production and cytotoxic effector function of human T cells
92. Testicular function in active ankylosing spondylitis. Therapeutic response to human chorionic gonadotrophin
93. 125I] testosterone in patient's serum: A problem for the laboratory and the patient
94. Gonadal function in men with chronic illness
95. Evaluation of diagnostic criteria for ankylosing spondylitis: A proposal for modification of the New York criteria
96. Diminished incidence of severe rheumatoid arthritis associated with oral contraceptive use
97. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a Th2 phenomenon?
98. The aetiology of ankylosing spondylitis
99. Neuroendocrine-immune system interactions and autoimmunity
100. Is there sexual inequality in ankylosing spondylitis? A study of 498 women and 1202 men
101. Prominent sex steroid metabolism in human lymphocytes